Previously reported Histone H3 lysine 27 acetylation (H3K27) ChIP-sequencing (ChIP-seq) data of an IDH-mutant cell line and tumor tissue also showed peaks associated with an active promoter region around the transcription start site of MKNL1, but not around that of MET (Fig. 6b). This evidence concerns the gene IDH2 and neoplasm.